THB ASSET MANAGEMENT - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
THB ASSET MANAGEMENT ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$3,346,000
-42.4%
80,900
-37.4%
0.25%
-37.4%
Q1 2015$5,809,000
+132.7%
129,321
+93.8%
0.41%
+146.1%
Q4 2014$2,496,000
+55.5%
66,724
+45.1%
0.16%
+48.6%
Q3 2014$1,605,000
-37.2%
45,980
-25.6%
0.11%
-34.7%
Q2 2013$2,554,00061,7700.17%
Other shareholders
HAEMONETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders